These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20114113)

  • 1. Combination brimonidine and timolol.
    Kerr NM; Gross KA; Tombleson M; Danesh-Meyer HV
    Ophthalmology; 2010 Jan; 117(1):193-193.e1. PubMed ID: 20114113
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Osborne SA; Montgomery DM; Morris D; McKay IC
    Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic brimonidine before LASIK.
    Uretmen O; Ates H; Andaç K
    J Refract Surg; 2003; 19(5):612. PubMed ID: 14518756
    [No Abstract]   [Full Text] [Related]  

  • 9. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
    Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
    Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing.
    Chu MB; Searcy G; Siegfried E
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
    Konstas AG; Katsimpris IE; Kaltsos K; Georgiadou I; Kordelou A; Nelson LA; Stewart WC
    Eye (Lond); 2008 Nov; 22(11):1391-7. PubMed ID: 17571086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
    Nguyen EV; Azar D; Papalkar D; McCluskey P
    J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-2 adrenergic agonists in the treatment of glaucoma].
    Apătăchioae I; Chiseliţă D
    Oftalmologia; 1999; 47(2):35-40. PubMed ID: 10641099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timolol, carotid sinus hypersensitivity, and elderly patients.
    Mulcahy R; Allcock L; O'Shea D
    Lancet; 1998 Oct; 352(9134):1147-8. PubMed ID: 9798617
    [No Abstract]   [Full Text] [Related]  

  • 17. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine--an alpha 2-agonist for glaucoma.
    Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications of local pharmacotherapy in ophthalmology].
    Mozherenkov VP; Ukhaneva GL
    Vestn Oftalmol; 1985; 101(1):62-5. PubMed ID: 2858932
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
    Whitson JT; Ochsner KI; Moster MR; Sullivan EK; Andrew RM; Silver LH; Wells DT; James JE; Bosworth CF; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2006 Aug; 113(8):1333-9. PubMed ID: 16877072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.